Temporal profiling of the transcriptional basis for the development of corticosteroid-induced insulin resistance in rat muscle

被引:44
作者
Almon, RR [1 ]
DuBois, DC
Jin, JY
Jusko, WJ
机构
[1] SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA
[2] SUNY Buffalo, Dept Pharmaceut Sci, Buffalo, NY 14260 USA
关键词
D O I
10.1677/joe.1.05953
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Elevated systemic levels of glucocorticoids are causally related to peripheral insulin resistance. The pharmacological use of synthetic glucocorticoids (corticosteroids) often results in insulin resistance/type II diabetes. Skeletal muscle is responsible for close to 80% of the insulin-induced systemic disposal of glucose and is a major target for glucocorticoid-induced insulin resistance. We used Affymetrix gene chips to profile the dynamic changes in mRNA expression in rat skeletal muscle in response to a single bolus dose of the synthetic glucocorticoid methylprednisolone. Temporal expression profiles (analyzed on individual chips) were obtained from tissues of 48 drug-treated animals encompassing 16 time points over 72 h following drug administration along with four vehicle-treated controls. Data mining identified 653 regulated probe sets out of 8799 present on the chip. Of these 653 probe sets we identified 29, which represented 22 gene transcripts, that were associated with the development of insulin resistance. These 29 probe sets were regulated in three fundamental temporal patterns. 16 probe sets coding for 12 different genes had a profile of enhanced expression. 10 probe sets coding for eight different genes showed decreased expression and three probe sets coding for two genes showed biphasic temporal signatures. These transcripts were grouped into four general functional categories: signal transduction, transcription regulation, carbohydrate/fit metabolism, and regulation of blood flow to the muscle. The results demonstrate the polygenic nature of transcriptional changes associated with insulin resistance that can provide a temporal scaffolding for translational and post-translational data as they become available.
引用
收藏
页码:219 / 232
页数:14
相关论文
共 83 条
[1]   Alterations in skeletal muscle protein-tyrosine phosphatase activity and expression in insulin-resistant human obesity and diabetes [J].
Ahmad, F ;
Azevedo, JL ;
Cortright, R ;
Dohm, GL ;
Goldstein, BJ .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (02) :449-458
[2]   INCREASED ABUNDANCE OF SPECIFIC SKELETAL-MUSCLE PROTEIN-TYROSINE PHOSPHATASES IN A GENETIC MODEL OF INSULIN-RESISTANT OBESITY AND DIABETES-MELLITUS [J].
AHMAD, F ;
GOLDSTEIN, BJ .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1995, 44 (09) :1175-1184
[3]   Differential effects of rexinoids and thiazolidinediones on metabolic gene expression in diabetic rodents [J].
Ahuja, HS ;
Liu, S ;
Crombie, DL ;
Boehm, M ;
Leibowitz, MD ;
Heyman, RA ;
Depre, C ;
Nagy, L ;
Tontonoz, P ;
Davies, PJA .
MOLECULAR PHARMACOLOGY, 2001, 59 (04) :765-773
[4]   The genomic response of skeletal muscle to methylprednisolone using microarrays: tailoring data mining to the structure of the pharmacogenomic time series [J].
Almon, RR ;
DuBois, DC ;
Piel, WH ;
Jusko, WJ .
PHARMACOGENOMICS, 2004, 5 (05) :525-552
[5]   Pharmacodynamics and pharmacogenomics of diverse receptor-mediated effects of methylprednisolone in rats using microarray analysis [J].
Almon, RR ;
DuBois, DC ;
Brandenburg, EH ;
Shi, W ;
Zhang, SZ ;
Straubinger, RM ;
Jusko, WJ .
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2002, 29 (02) :103-129
[6]  
[Anonymous], 1985, GUIDE CARE USE LAB A
[7]  
Araki Eiichi, 2002, Nihon Rinsho, V60 Suppl 7, P559
[8]   METABOLISM OF KETONE-BODIES BY SKELETAL-MUSCLE IN STARVATION AND UNCONTROLLED DIABETES [J].
BAILEY, JW ;
HAYMOND, MW ;
MILES, JM .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1990, 39 (10) :1039-1043
[9]   Expression of mRNAs encoding uncoupling proteins in human skeletal muscle - Effects of obesity and diabetes [J].
Bao, S ;
Kennedy, A ;
Wojciechowski, B ;
Wallace, P ;
Ganaway, E ;
Garvey, WT .
DIABETES, 1998, 47 (12) :1935-1940
[10]  
Baxter J D, 2000, Adv Intern Med, V45, P317